Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
36 Cards in this Set
- Front
- Back
What are orphan receptors?
|
receptors whose function is not yet determined
|
|
What is the EC50?
|
dose at that provides 50% of maximal effect
|
|
What is the Kd?
|
equilibrium dissociation constant; concentration of a drug where 50% is bound to receptors and 50% is free
|
|
What is "coupling" when discussing receptors?
|
the process of converting the binding of a receptor into an actual response
|
|
What happens to the EC50 of a drug if an antagonist is also administered?
|
the EC50 must rise to compensate for the additional antagonist. more drug is needed to provide 50% maximal effect since there is an antagonist working also. but there is a point where if the [antagonist] is too high, it is impossible for the agonist drug to even produce 50% effectiveness since it is out competed by the antagonist
|
|
What are spare receptors?
|
excess receptors that a cell may have; if we give an antagonist + agonist, we can still have a maximal effect (but it will require more agonist) since there are spare receptors to accommodate the antagonist
|
|
What is a temporal spare receptor?
|
only a few receptors are needed because binding of a drug/hormone to that receptor elicits a long response. therefore there are extra receptors that are not needed, since only a few can elicit a strong long term response
|
|
What is meant when receptors are spare in number?
|
there are physically more receptors than needed
|
|
Which will have a greater effect on diminishing a hormone's actions? Competitive inhibitor or non-competitive inhibitor?
|
non-competitive inhibitor has more inhibition. a competitive inhibitor still has to compete, a non-competitive inhibitor can just bind anywhere on the receptor prevent the drug from binding. With a competitive inhibitor, higher [drug] can overcome the inhibition. not true with a non-competitive inhibitor
|
|
Which is more likely of an irreversible antagonist? Covalent binding or electrostatic binding?
|
covalent binding typically = irreversible binding
|
|
What are allosteric modulators?
|
bind the receptor (not in drug's active site) and change the receptor's function (not necessarily inhibiting it though)
|
|
If the concentration of a full agonist is kept constant and concentration of a partial agonist is constantly increased, what will eventually happen?
|
the partial agonist will exert more of an effect compared to the full agonist. this will lead to the total overall response being lowered
|
|
How do lipid soluble drugs bind to their receptors and elicit a response?
|
they can diffuse into the cell and bind to their receptors in the cell/nucleus. this complex then binds to hormone responsive elements on the DNA that regulate transcription
|
|
How do tyrosine kinase receptors work to elicit a response?
|
hormone binds, tyrosine kinase on receptor initiates a kinase cascade.
|
|
What is "down-regulation" regarding the tyrosine kinase receptors?
|
after a hormone binds, the receptor is endocytosed and removed. if this process outpaces receptor synthesis, there is a decrease in # of receptors available = down regulation
|
|
How do the cytokine receptors work?
|
quick acting JAK/STAT pathway. JAK phosphorylates STAT, STAT dimerizes and enters the nucleus to regulate transcription
|
|
What happens when acetylcholine binds to nicotininc receptors?
|
opening of a voltage gated channel allowing Na to enter the neurons to cause depolarization
|
|
How do G protein receptors initiate a response in a cell?
|
hormone binds, G protein dissociates subunits, activate adenylyl cyclase or PLC, cAMP or DAG or IP3 initiate cascades
|
|
In a G protein receptor, dissociation of a Gq subunit has what direct effect in the cells?
|
activates phospholipase C which cleaves PIP2 into IP3 and DAG that will increase Ca++ levels
|
|
In a G protein receptor, dissociation of a Gs subunit has what direct effect in the cells?
|
activate adenylyl cyclase = more cAMP
|
|
In a G protein receptor, dissociation of a Gi subunit has what direct effect in the cells?
|
inhibit adenylyl cyclase = less cAMP
|
|
The B-adrenoreceptor is what type of receptor?
|
heptahelical G-protein receptor
|
|
How is cAMP degraded?
|
phosphodiesterases
|
|
cAMP has what effect on smooth muscle tone?
|
cAMP = smooth muscle relaxation
|
|
Function of phospholipase C
|
cleave PIP2 into DAG and IP3
|
|
Function of IP3
|
release intracellular Ca from sarcoplasmic reticulum
|
|
Function of DAG
|
activates protein kinase C
|
|
When discussing potency of a drug, what are we referring to?
|
the dosage (EC50) needed to provide an effect. a more potent drug will have a lower EC50, since less is needed to create an effect
|
|
When discussing efficacy of a drug, what are we referring to?
|
the potential maximal effect of a drug
|
|
What is LD50?
|
the dosage of a drug that will kill 50% of patients
|
|
What is ED50?
|
the dosage of a drug that creates a desired therapeutic effect in 50% of patients
|
|
What is TD50?
|
the dosage of a drug that will give toxic effects in 50% of patients
|
|
What is the therapeutic index?
|
ratio of TD50:ED50 to related the doses therapeutic and toxic capabilities
|
|
Which piece of data would tell us variability of drug effects in patients? Graded dose curve of Quantal dose curve?
|
Quantal dose curve
|
|
What is an idiosynchratic response?
|
response to a drug that is not commonly seen
|
|
If a patient is hyporeactive to a drug, what would we need to do to adjust the dosage?
|
increase dosage since the patient is less responsive to the medication
|